| 9.30-10.00 |
Registration, welcome coffee |
| 10.00-10.05 |
Opening |
| 10.05-10.30 |
1
|
G.
Somlyai: NATURALLY OCCURRING DEUTERIUM ISESSENTIAL FOR THE NORMAL
GROWTH RATE OF CELLS |
| 10.30-10.50 |
2
|
G.
Jancso: PHYSIOLOGICAL EFFECTS OF HEAVYWATER |
| 10.50-11.15 |
3
|
W.
Bild, V Bild, I. Haulica: ENVIRONMENTALDEUTERIUM AND CELL PROLIFERATION:
IMPLICATIONS IN RADIOBIOLOGY |
| 11.15-11.40 |
4
|
Y.
Sinyak: RECOVERY AND USE OF DEUTERIUM-FREEWATER IN EXTENDED SPACE
EXPEDITION |
| 11.40-12.00 |
5
|
D.S.
de Avila, M. Aschner: PROTECTIVEEFFECTS OF DDW IN CAENORHABDITIS
ELEGANS |
| 12.00-13.00 |
Lunch |
| 13.00-13.35 |
6
|
Boros,
G.Somlyai: INTERMEDIARY METABOLISMAND MACROMOLECULE SYNTHESIS
IN RESPONSE TO DEUTERIUM DEPLETION INPANCREATIC, BREAST AND LUNG
CANCER CELL LINES |
| 13.35-13.50 |
7
|
G.
Laskay: CELL PHYSIOLOGICAL EFFECTS OFREDUCED DEUTERIUM CONTENT
IN THE LEAVES OF ELODEA CANADENSIS |
| 13.50-14.05 |
8
|
Z.
Gyongyi, F. Budan, I. Szabo, G. Somlyai: DEUTERIUM DEPLETION AND
HYPERTHERMIC SENSITIVITY |
| 14.05-14.25 |
9
|
M.
Molnar, K. Horvath, T. Danko, G. Somlyai: EFFECT OF DEUTERIUM
OXIDE (D2O) CONTENT OF DRINKING WATER ON GLUCOSEMETABOLISM IN
STZ-INDUCED DIABETIC RATS |
| 14.25-14.40 |
10
|
M.
Szabo, T.Berkenyi, G. Somlyai: THE EFFECT OF DEUTERIUM DEPLETION
ON ANIMAL TUMORS. TEN-YEAR EXPERIENCEWITH VETERA-DDW-25 A.U.V.
IN VETERINARY THERAPY |
| 14.40-15.10 |
Coffeebreak |
| 15.10-15.30 |
11
|
G.
Somlyai, I. Guller, K. Krempels, I.Somlyai, A. Kovacs: STATISTICAL
EVALUATION OF THE CONSUMPTION OFDEUTERIUM-DEPLETED WATER AS AN
EFFECTIVE TREATMENT OPTION FOR PROSTATECANCER, A DOUBLE BLIND,
RANDOMIZED PHASE II CLINICAL TRIAL |
| 15.30-15.50 |
12
|
K.
Krempels, I. Somlyai, M. Huszar, G.Somlyai: A RETROSPECTIVE STUDY
TO EVALUATE THE EFFECT OF DEUTERIUMDEPLETION ON THE SURVIVAL OF
METASTATIC BREAST CANCER PATIENTS |
| 15.50-16.10 |
13
|
I.
Stefanescu,T.
Nicola, C. Mladin, R.Tamaian, V. Niculescu, V. Feurdean, G. Ti?escu,
N. P?un: STUDIESCONCERNING DDW USE FOR DEUTERIUM’S DEPLETION IN
ANIMAL ORGANISM AND FORSYNTHESIS OF NEW NAPHTHOQUINONIC ANTITUMORAL
COMPOUNDS |
| 15.10-16.25 |
14
|
Z.
Gyongyi, F. Budan, I. Szabo: LUNG CANCERAND DEUTERIUM DEPLETION.
CLINICAL AND EXPERIMENTAL DATA |
| 15.25-16.50 |
15
|
G.
Somlyai: BASIC RULES OF THE APPLICATIONOF DEUTERIUM DEPLETION
IN COMBINATION WITH CONVENTIONAL ONCOTHERAPIES |
| 16.50-17.00 |
Closing |
| 18.00- |
Reception |
